Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1323645 PARIS, I0

Position in ALNY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$46,931,781
+$573,917 QoQ
Shares Held
155,904
+11.3% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#88
of 784 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Derivatives in ALNY

reported options exposure · as of Mar 31, 2020
CallValue
$1,502,130
CallShares
13,800
PutValue
$1,077,615
PutShares
9,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $326,278,392 across 42 Biotechnology names. ALNY ranks #1 (14.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
This page
155,904 $46,931,781

All Filings in ALNY

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,931,781 155,904
2026-03-31 $46,357,864 140,109
2025-12-31 $8,326,791 20,940
2024-06-30 $10,162,503 41,821
2024-03-31 $4,538,348 30,367
2020-03-31 $1,502,130 13,800
2020-03-31 $906,938 8,332
2020-03-31 $1,077,615 9,900